A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain
Stopped No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.
Conditions
- Leptomeningeal Metastasis From Malignant Melanoma
Interventions
- RADIATION: Brain radiotherapy (WBRT alone, SRT/SRS alone or WBRT plus SRT/SRS)
- DRUG: Lomustine
- DRUG: Liposomal cytarabine
Sponsor
University Hospital, Bonn
Collaborators